XRCC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.186200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.297600E-01
Normal-vs-Stage2
8.622200E-01
Normal-vs-Stage3
4.997400E-01
Normal-vs-Stage4
6.092400E-01
Stage1-vs-Stage2
3.834100E-02
Stage1-vs-Stage3
7.203400E-01
Stage1-vs-Stage4
7.210000E-01
Stage2-vs-Stage3
2.398000E-01
Stage2-vs-Stage4
5.106800E-01
Stage3-vs-Stage4
6.480400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.458800E-01
Normal-vs-AfricanAmerican
5.198000E-01
Normal-vs-Asian
7.468000E-01
Caucasian-vs-AfricanAmerican
9.104300E-02
Caucasian-vs-Asian
5.364400E-01
AfricanAmerican-vs-Asian
1.976560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.406600E-01
Normal-vs-Female
7.969800E-01
Male-vs-Female
5.938000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.779800E-01
Normal-vs-Age(41-60Yrs)
8.009200E-01
Normal-vs-Age(61-80Yrs)
6.605800E-01
Normal-vs-Age(81-100Yrs)
8.188800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.382400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.298200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.117200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.022200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.098400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.158200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.401800E-01
Normal-vs-Daily Drinker
9.013800E-01
Normal-vs-Weekly Drinker
9.367800E-01
Normal-vs-Occasional Drinker
8.074800E-01
Normal-vs-Social Drinker
9.711000E-01
Non Drinker-vs-Daily Drinker
8.277000E-01
Non Drinker-vs-Weekly Drinker
6.599800E-01
Non Drinker-vs-Occasional Drinker
7.093000E-01
Non Drinker-vs-Social Drinker
5.624000E-01
Daily Drinker-vs-Weekly Drinker
7.744000E-01
Daily Drinker-vs-Occasional Drinker
5.380400E-01
Daily Drinker-vs-Social Drinker
6.705400E-01
Weekly Drinker-vs-Occasional Drinker
4.775600E-01
Weekly Drinker-vs-Social Drinker
9.280400E-01
Occasional Drinker-vs-Social Drinker
3.880400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.845200E-01
Normal-vs-Grade 2
8.641400E-01
Normal-vs-Grade 3
9.004800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.717640E-01
Grade 1-vs-Grade 3
4.911900E-02
Grade 1-vs-Grade 4
7.845200E-01
Grade 2-vs-Grade 3
4.790200E-01
Grade 2-vs-Grade 4
8.641400E-01
Grade 3-vs-Grade 4
9.004800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.948800E-01
Normal-vs-NonDiabetic
8.753000E-01
Diabetic-vs-NonDiabetic
4.463800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.328600E-01
Normal-vs-NoPancreatitis
8.288800E-01
Pancreatitis-vs-NoPancreatitis
5.444200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.885800E-01
Normal-vs-N1
8.365400E-01
N0-vs-N1
5.980400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.990800E-01
Normal-vs-TP53-NonMutant
7.462400E-01
TP53-Mutant-vs-TP53-NonMutant
1.897200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
